Exploration of biomarkers to predict the effects of anti TSLP antibody (Tezepelumab) in refractory asthma patients using comprehensive analyses of changes in gene expression in whole blood cells
Not Applicable
Recruiting
- Conditions
- Severe asthma
- Registration Number
- JPRN-UMIN000050670
- Lead Sponsor
- Department of Respiratory Medicine, University of Tsukuba
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
1. Patients with serious complications such as uncontrolled heart disease, diabetes mellitus, or gastrointestinal hemorrhage 2. Patients with active local or systemic infection requiring treatment 3. Patients with a history of serious hypersensitivity 4. Patients whose enrollment in this study is considered to be difficult due to clinically significant psychiatric disorders 5. Other patients considered ineligible for this study by the principal investigator/sub-investigator
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method